Search research articles
Contact Us
Filters
Showing results (451-460 of 607) with videos related to
Page
of 61
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 17, 2020
Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsets
P Moinzadeh, P Frommolt, M Franitza, et al.
The European Respiratory Journal
|
February 22, 2020
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler, Shervin Assassi, Vincent Cottin, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 8, 2007
Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts
Xu Shi-Wen, Elisabetta A Renzoni, Laura Kennedy, et al.
Rheumatology (Oxford, England)
|
May 18, 2022
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis
Christopher P Denton, Francesco Del Galdo, Dinesh Khanna, et al.
Rheumatology (Oxford, England)
|
February 1, 2022
Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective
Puja Mehta, Rachel K Hoyles, Harsha Gunawardena, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 26, 2023
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines
Oliver Distler, Diana Bonderman, J Gerry Coghlan, et al.
Clinical and Experimental Rheumatology
|
February 27, 2026
Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world cohort study on tolerability and discontinuation
Punchalee Kaenmuang, Nina R Goldman, Arthihai Srirangan, et al.
Seminars in Arthritis and Rheumatism
|
February 6, 2025
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study
Julia Spierings, Giulia Bandini, Yannick Allanore, et al.
Annals of the Rheumatic Diseases
|
July 27, 2006
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
M H Buch, C P Denton, D E Furst, et al.
The Journal of Rheumatology
|
November 3, 2017
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study
Vivien M Hsu, Christopher P Denton, Robyn T Domsic, et al.
Page
of 61
Search research articles
Search
Showing results (451-460 of 607) with videos related to
Sort By:
Page
of 61
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 17, 2020
Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsets
P Moinzadeh, P Frommolt, M Franitza, et al.
The European Respiratory Journal
|
February 22, 2020
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler, Shervin Assassi, Vincent Cottin, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 8, 2007
Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts
Xu Shi-Wen, Elisabetta A Renzoni, Laura Kennedy, et al.
Rheumatology (Oxford, England)
|
May 18, 2022
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis
Christopher P Denton, Francesco Del Galdo, Dinesh Khanna, et al.
Rheumatology (Oxford, England)
|
February 1, 2022
Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective
Puja Mehta, Rachel K Hoyles, Harsha Gunawardena, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 26, 2023
Performance of DETECT Pulmonary Arterial Hypertension Algorithm According to the Hemodynamic Definition of Pulmonary Arterial Hypertension in the 2022 European Society of Cardiology and the European Respiratory Society Guidelines
Oliver Distler, Diana Bonderman, J Gerry Coghlan, et al.
Clinical and Experimental Rheumatology
|
February 27, 2026
Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world cohort study on tolerability and discontinuation
Punchalee Kaenmuang, Nina R Goldman, Arthihai Srirangan, et al.
Seminars in Arthritis and Rheumatism
|
February 6, 2025
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study
Julia Spierings, Giulia Bandini, Yannick Allanore, et al.
Annals of the Rheumatic Diseases
|
July 27, 2006
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
M H Buch, C P Denton, D E Furst, et al.
The Journal of Rheumatology
|
November 3, 2017
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study
Vivien M Hsu, Christopher P Denton, Robyn T Domsic, et al.
Page
of 61